Key result
Brugada syndrome linked to ~14 ms longer propagation progression times at 70% QRS energy.
Why the study?
Brugada syndrome is associated with delayed and heterogeneous ventricular activation, but a quantitative non-invasive spatiotemporal characterization using high-precordial ECG is needed.
Does ECG-based propagation progression time (PPT) distinguish between Brugada syndrome patients and controls?
Observational (n=162)
Does ECG-based propagation progression time (PPT) distinguish between Brugada syndrome patients and controls?
Absolute Event Rate: 74% vs 60%
p-value: p=< 0.001
ECG-based propagation progression time analysis provides a quantitative, non-invasive method to characterize delayed and heterogeneous ventricular activation in Brugada syndrome.
OBJECTIVE: Brugada syndrome (BrS) has been associated with delayed and heterogeneous electrical activation, particularly involving the RVOT. This study proposes a spatiotemporal characterization of ventricular activation using the high-precordial 12-lead electrocardiogram (ECG). METHODS: Delayed ventricular activation was quantified by a lead-dependent propagation progression time (PPT), defined as the time instant within the QRS complex at which 30%, 50%, or 70% of cumulative QRS energy is reached. PPTs were calculated every 30 minutes and characterized temporally, by their 24-hour median and standard deviation, and spatially, by their maximum inter-lead differences. The method was evaluated on 162 subjects (118 patients, 44 controls). RESULTS: BrS patients exhibited significantly longer PPTs across all leads than controls. The largest difference was observed at 70% QRS energy (median PPT in lead V22IC: BrS 74[63;87]ms vs control 60[56;66]ms, p-value< 0.001). Increased spatial dispersion of PPT was observed in male patients (maximum inter-lead difference: male 20[12;26]ms vs female 12[9;20]ms, p-value< 0.01), potentially reflecting sex-related differences in ventricular conduction patterns. The intra-subject temporal variability of PPT at 70% QRS energy can distinguish between controls and BrS patients with induced type-I ECG pattern (AUC>0.75 in leads V22IC and V13IC). CONCLUSION: PPT analysis captures the spatiotemporal dynamics of delayed and heterogeneous ventricular activation associated with BrS and provides a quantitative non-invasive characterization of conduction abnormalities. SIGNIFICANCE: Developing a non-invasive ECG-based approach for the assessment of ventricular conduction dynamics may complement current non-invasive ECG-based diagnostic tools in BrS, even in patients without spontaneous type-I pattern manifestation.
No takes yet. Share an insight, caveat, or question.
Romagnoli et al. (2026) conducted an observational in Brugada syndrome (n=162). Brugada syndrome vs. Controls was evaluated on Propagation progression time (PPT) at 70% QRS energy in lead V2_{2IC} (p=< 0.001). Brugada syndrome patients exhibited significantly longer median propagation progression times at 70% QRS energy compared to controls (74 ms vs 60 ms; P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: